Colorectal Cancer
Entity.
- Evidence
- 2,109 documents · 432 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 10 Nov 2026
- Measured
- 6% of mentions say something specific about it; the rest only name it
- As of
- 11 Nov 2026
Where this comes from
- Eur J Cancer Prev · 2026-11-10 · Trends in breast, cervical, and colon cancer incidence and mortality rates in Türkiye: national evaluation of three population-based screening-targeted cancers. (opens the source in a new tab)
- Nature · 2026-11-10 · Microbiota-based modulation of intratumoral cholesterol metabolism for colorectal cancer treatment (opens the source in a new tab)
- Eur J Cancer Prev · 2026-11-10 · Colorectal cancer screening beliefs and general health-seeking behavior among hospitalized adults aged 50-70 years in Türkiye: a cross-sectional study. (opens the source in a new tab)
- Probiotics Antimicrob Proteins · 2026-11-09 · Sodium Butyrate: A Microbiota-Derived Short-Chain Fatty Acid Regulating Inflammation, Gut Barrier Function, and Colorectal Cancer Progression. (opens the source in a new tab)
- Gene · 2026-11-09 · Nonylphenol-responsive MIR200CHG modulates colorectal cancer cell proliferation, migration, and invasion through EPS8L1. (opens the source in a new tab)
- Med Oncol · 2026-11-09 · Fatty acid binding protein 1, a differentially expressed metabolism-related gene in colorectal cancer, modulates the malignant phenotypes of cancer cells via modulating PPARγ. (opens the source in a new tab)
- Cancer Lett · 2026-11-09 · Effective Targeting of p53-Mutant Colorectal and Pancreatic Cancers by Combinatorial Therapeutic Strategy. (opens the source in a new tab)
- J Control Release · 2026-11-09 · Dual drug delivery via integrin-targeted nanoparticles enhances therapeutic efficiency in BRAFV600E colon cancer. (opens the source in a new tab)
- MedComm (2020) · 2026-11-08 · SHP1-Mediated FTO Dephosphorylation Regulates Mitophagy and Promotes Tumor Progression via N(6)-Methyladenosine in Colorectal Cancer. (opens the source in a new tab)
- Medical Xpress · 2026-11-08 · Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases (opens the source in a new tab)
- OncoDaily · 2026-11-08 · Agenus Reports Long-Term Survival Outcomes of BOT+BAL in Refractory MSS Colorectal Cancer at SITC 2026 (opens the source in a new tab)
What is claimed about it
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- Sotorasib plus panitumumab extends progression-free survival in KRAS G12C-mutant colorectal cancer Could not check · first reported 7 Nov 2026
- Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026 - BioSpace Single source · first reported 6 Nov 2026
- Comparative efficacy and safety of second- and later-line BRAF-targeted regimens in BRAF V600E-mutant metastatic colorectal cancer: A systematic review and network meta-analysis. Could not check · first reported 6 Nov 2026